D. Blissett

发表

The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe

Robert Blissett, Rachel Beckerman, Andrei Racila, 2016, Hepatology.

The Role of Health Technology Assessment in the Adoption of New Technologies in Diabetes Care: A Review of HTA Reports on Freestyle Libre

D. Blissett, R. Beckerman, C. Saborido, 2019 .

Budget Impact of the Flash Continuous Glucose Monitoring System in Medicaid Diabetes Beneficiaries Treated with Intensive Insulin Therapy.

D. Blissett, Jerry R Frank, R. Hellmund, 2021, Diabetes technology & therapeutics.

FreeStyle Libre Flash Glucose Monitoring system for people with type 1 diabetes in the UK: a budget impact analysis

E. Wilmot, Robert S Blissett, T. Sathyapalan, 2022, BMJ Open Diabetes Research & Care.

Targeted case finding for chronic obstructive pulmonary disease versus routine practice in primary care (TargetCOPD): a cluster-randomised controlled trial.

D. Fitzmaurice, R. Stockley, R. Riley, 2016, The Lancet. Respiratory medicine.

Search strategies for cost-effectiveness studies: review 3

Richard D Riley, Rachel Jordan, Saimma Majothi, 2015 .

Premature and Incomplete Overview of Health Technology Assessments for Flash Glucose Monitoring Leads to Misleading Conclusions

D. Blissett, Fleur Levrat-Guillen, R. Hellmund, 2018, Journal of diabetes science and technology.

Minimally Invasive Sacroiliac Joint Fusion with Triangular Titanium Implants: Cost-Utility Analysis from NHS Perspective

D. Cher, Robert S Blissett, D. Blissett, 2020, PharmacoEconomics - Open.

Effect of Pay-For-Outcomes and Encouraging New Providers on National Health Service Smoking Cessation Services in England: A Cluster Controlled Study

M. Mohammed, D. Blissett, Steven Wyatt, 2015, PloS one.

Supported self-management for patients with moderate to severe chronic obstructive pulmonary disease (COPD): an evidence synthesis and economic analysis.

Sally J. Singh, D. Fitzmaurice, M. Price, 2015, Health technology assessment.

The cost-effectiveness of domiciliary non-invasive ventilation in patients with end-stage chronic obstructive pulmonary disease: a systematic review and economic evaluation.

M. Price, A. Turner, S. Jowett, 2015, Health technology assessment.

Cost Calculation for a Flash Glucose Monitoring System for Adults with Type 2 Diabetes Mellitus Using Intensive Insulin – a UK Perspective

R. Weitgasser, D. Blissett, R. Hellmund, 2018, European endocrinology.

Economic value of narrow band imaging versus white light endoscopy for the characterization of diminutive polyps in the colon: systematic literature review and cost-consequence model

Z. Ihara, Romy Klausnitzer, D. Blissett, 2016, Journal of medical economics.

Analysis Estimating the Potential Cost Impact of Utilizing Flash Glucose Monitoring with Optional Alarms in Swedish Adults with Diabetes with Impaired Awareness of Hypoglycaemia, Using Intensive Insulin

S. Attvall, D. Blissett, R. Hellmund, 2021, Diabetes Therapy.

Cost calculation for a flash glucose monitoring system for UK adults with type 1 diabetes mellitus receiving intensive insulin treatment.

R. Weitgasser, D. Blissett, R. Hellmund, 2018, Diabetes research and clinical practice.

Supported self-management for patients with moderate to severe chronic obstructive pulmonary disease (COPD): an evidence synthesis and economic analysis.

Elizabeth J Bates, Sally J. Singh, D. Fitzmaurice, 2015, Health technology assessment.

Breathing Synchronised Hypoglossal Nerve Stimulation with Inspire for Untreated Severe Obstructive Sleep Apnoea/Hypopnoea Syndrome: A Simulated Cost-Utility Analysis from a National Health Service Perspective

Robert S Blissett, J. Steier, D. Blissett, 2021, PharmacoEconomics - Open.